Big Pharma companies have built empires out of human pain without managing to come close to addressing the number one cause of disability in the world: Depression, a disease that costs the economy a trillion dollars in lost production every year.
But while Big Pharma is turning over billions in...
Strong Earnings Are No Longer Enough
The investment community just watched one of the market’s most compelling narratives hit a significant speed bump. Nvidia, the undisputed kingmaker of the artificial intelligence boom, delivered an earnings report that was, by all accounts, extraordinarily good.
Yet, the market’s reaction was anything but celebratory,...
As we kick off the final week of the month and second quarter, the S&P 500 is flirting with record highs despite a slight wobble in tech stocks like Nvidia. For equity bulls, the stars seem aligned with seasonal factors providing a supportive backdrop.
In today’s issue, we dive into...
Thousands of years ago, ancient Aztecs may have held the key to the next biotech breakthrough.
During ceremonial rituals, they used a special compound they called “the flesh of the gods”...
And today, researchers are discovering that this same compound could transform how we approach mental health moving forward…
Sparking an explosion...
As the curtain closes on the stock market’s acclaimed ‘good’ season, we stand at the crossroads of profit and prudence. With portfolios plumped up like Thanksgiving turkeys, thanks to a 22% feast since November, the temptation to pocket those gains and saunter into summer is palpable.
But before you decide...
Global Investment Daily Featured Stock: Hims & Hers Health Inc.
In the labyrinth of financial markets, where the allure of fast-paced tech stocks often overshadows the steady drumbeat of more traditional sectors, healthcare stocks tend to whisper rather than shout for investors’ attention.
Traditionally viewed as the tortoises in a race...
Over the past 2 years Bitcoin and other cryptocurrencies have been hammered as investors headed toward the exits. Major brokers were in flux in 2022 when Binance refused to buy out Sam Bankman-Fried’s FTX exchange. Some experts warned that Bitcoin could fall as low as $9,000.
Simply put, the Bitcoin...
Since 2020, we have all felt the impact of inflation in our lives. We’ve felt the rising costs of gasoline, eggs, meat, rent and other daily necessities.
Interest rate hikes, designed to cool down runaway inflation. Whle interest rates surged from under 3% to 6.5%, new 30-day mortgage interest rates...
Ready for Tactical Tuesday? Today, we're zeroing in on the Dow Jones Industrial Average and its tantalizing approach to the 40,000 mark. It seems that the wall of investor psychology has it playing hard to get. But history suggests a breakthrough could mean above-average performance for the Dow!
Speaking of...
Bitcoin has been surging lately. The cryptocurrency has rallied nearly 70% from $26,000 in October to recent highs of $44,000.
The popular cryptocurrency still has a way to go to get back to its historic price level of nearly $69,000, set in November 2021.
It appears that Bitcoin and other cryptocurrencies...
